Home » Topics » BioWorld Science

BioWorld Science
RSS

New Iomeron formulation introduced in Japan

July 5, 1996

Cathepsin B inhibitor shows potential in gingivitis

July 5, 1996

Lilly discloses antiobesity proteins

July 5, 1996

NPY1 ligands claimed by Pfizer

July 5, 1996

Low-dose lovastatin + niacin shows good efficacy and safety in patient study

July 5, 1996

Ono terminates CholestaGel agreement with GelTex

July 5, 1996

Fortical phase I dosing data revised

July 5, 1996

HHS scientist discovers cartilage formation stimulant

July 5, 1996

FDA will review BioLon PMA

July 5, 1996

Vertex begins phase II study of VX-710

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...